Back to mobile site

More on PTGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Protagonist Therapeutics (NQ:PTGX)
Delayed: 118.96 +3.93 (3.42%)
Prev. Close $115.03  
Open$114.66 
52 Wk High$24.52 
52 Wk Low$10.02 
Day High$119.85 
Day Low$114.56 
P/E N/A  
EPS$0.00 
Volume700,455 

Friends, Peers and Foes (?): TAK, JNJ, ACLX, ACU, AMLX (more...)

Jun 23, 2026 04:27 PM Form 144 Protagonist Therapeutics Filed by: Waddill William D.
Jun 18, 2026 04:31 PM Form 8-K Protagonist Therapeutics For: Jun 17
Jun 16, 2026 04:01 PM Protagonist Therapeutics Reports Granting of Inducement Awards
Jun 11, 2026 07:07 PM Form 4 Protagonist Therapeutics For: Jun 10 Filed by: Waddill William D.
Jun 10, 2026 04:30 PM Form 144 Protagonist Therapeutics Filed by: Waddill William D.
Jun 1, 2026 06:31 PM Form 4 Protagonist Therapeutics For: May 29 Filed by: Waddill William D.
May 29, 2026 04:23 PM Form 144 Protagonist Therapeutics Filed by: Waddill William D.
May 28, 2026 07:05 AM Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026
May 21, 2026 05:32 AM Wolfe Research Starts Protagonist Therapeutics (PTGX) at Outperform
May 14, 2026 08:07 PM Form 4/A Protagonist Therapeutics For: May 12 Filed by: PATEL DINESH V PH D
View All Articles

Entities mentioned with PTGX

View All Entities